101
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      一个复合杂合突变导致的遗传性凝血因子V缺陷症家系 Translated title: Analysis of a pedigree with inherited factor V deficiency caused by compound heterozygous mutation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          目的

          探讨一个遗传性凝血因子Ⅴ(FⅤ)缺陷症家系的分子致病机制。

          方法

          DNA直接测序法分析先证者F5的全部外显子、侧翼序列、5′和3′端非翻译区及家系成员(共3代11人)相应的突变位点区域。通过CAT法检测凝血酶生成量;用ClustalX软件分析突变位点的保守性;用MutationTaster、PolyPhen-2、PROVEAN、LRT和SIFT等在线生物信息学软件预测突变位点对蛋白质功能的影响;用Swiss-PdbViewer软件分析氨基酸突变前后蛋白模型及分子间作用力的变化。

          结果

          先证者F5第8外显子存在c.1258G>T杂合错义突变(p.Gly392Cys)及第14外显子存在c.4797delG杂合缺失突变,导致框移并产生截断蛋白(p.Glu1572Lys fsX19);其祖父和父亲存在p.Gly392Cys杂合突变;其外祖母、母亲、小姨母和表妹均存在p.Glu1572Lys fsX19杂合突变。先证者凝血酶生成延迟和达峰时间比值明显增高。保守性分析结果表明,p.Gly392在10种同源物种中位于保守区域。五个在线生物信息学软件对p.Gly392Cys预测均显示为致病的突变,Mutation Taster对p.Glu1572Lys fsX19预测也显示为致病突变。蛋白模型分析显示,Gly392突变为Cys392后可导致原有氢键延长,并形成新的空间位阻,影响蛋白结构的稳定性。

          结论

          该家系F5第8外显子c.1258G>T杂合错义突变及第14外显子c.4797delG杂合缺失突变可能与该家系FⅤ水平降低有关。

          Translated abstract

          Objective

          To explore the molecular pathogenesis of a family with hereditary factor Ⅴ(FⅤ)deficiency.

          Methods

          All the exons, flanking sequences, 5′ and 3′ untranslated regions of the F5 of the proband, and the corresponding mutation sites of the family members were analyzed via direct DNA sequencing. The CAT measurement was used to detect the amount of thrombin produced. The ClustalX software was used to analyze the conservation of mutation sites. The online bioinformatics software, Mutation Taster, PolyPhen-2, PROVEAN, LRT, and SIFT were applied to predict the effects of mutation sites on protein function. The Swiss-PdbViewer software was used to analyze the changes in the protein model and intermolecular force before and after amino acid variation.

          Results

          The proband had a heterozygous missense mutation c.1258G>T(p.Gly392Cys)in exon 8 of the F5, and a heterozygous deletion mutation c.4797delG(p.Glu1572Lys fsX19)in exon 14, which results in a frameshift and produces a truncated protein. Her grandfather and father had p.Gly392Cys heterozygous variation, whereas her maternal grandmother, mother, little aunt, and cousin all had p.Glu1572LysfsX19 heterozygous variation. The ratio of proband's thrombin generation delay to peak time was significantly increased. Conservation analysis results showed that p.Gly392 was located in a conserved region among the 10 homologous species. Five online bioinformatics software predicted that p.Gly392Cys was pathogenic, and Mutation Taster also predicted p.Glu1572Lys fsX19 as a pathogenic variant. Protein model analysis showed that the replacement of Gly392 by Cys392 can lead to the extension of the original hydrogen bond and the formation of a new steric hindrance, which affected the stability of the protein structure.

          Conclusion

          The c.1258G>T heterozygous missense mutation in exon 8 and the c.4797delG heterozygous deletion mutation in exon 14 of the F5 may be responsible for the decrease of FⅤ levels in this family.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: not found

          Factor V deficiency.

          Congenital factor V (FV) deficiency is a bleeding disorder associated with mild to severe hemorrhagic symptoms and a prevalence in the general population of 1 in 1,000,000 in the homozygous form. Patients with FV deficiency and clinically significant manifestations (mainly involving mucosal tracts) show very low or unmeasurable plasma FV levels and are usually homozygous or compound heterozygous for mutations located in the FV gene ( F5). Heterozygous carriers have approximately half-normal levels of FV and are usually asymptomatic. Replacement therapy for FV-deficient patients can only rely on administration of fresh-frozen plasma because specific FV concentrates are unavailable and FV is not present in cryoprecipitate or prothrombin complex concentrates. A total of 56 mutations have been published to date as being responsible for severe or moderately severe FV deficiency; more than two thirds of these are null mutations (mainly decreasing FV expression), with the remaining being missense mutations (usually impairing FV secretion). This article will provide a concise description of the FV protein and gene and will review the molecular, clinical, and therapeutic aspects of FV deficiency.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Asp68His mutation in the A1 domain of human factor V causes impaired secretion and ineffective translocation.

            Congenital factor V (FV) deficiency is a rare inherited disorder. We determined the mechanism of a missense mutation, Asp68His, in the A1 domain of the FV protein, is associated with severe FV deficiency. We characterized the mutant FV-Asp68His protein using in vitro expression studies by using specific secretion and degradation pathway inhibitors and analysed the intracellular translocation of the mutant protein by immunofluorescence staining. The Asp68His mutation caused very low levels of FV protein in the conditioned media, with normal specific FV activity. Similar mRNA degradation rates between FV-wild-type (wt) and FV-Asp68His mRNA showed that the Asp68His mutation does not affect FV expression at the transcriptional level. A specific secretion pathway inhibitor, brefeldin A, was used to demonstrate that the lower efficiency of transport to the outside of the cell for FV-Asp68His mutant protein compared with that of the FV-wt protein. Furthermore, we showed that the Asp68His mutation resulted in increased intracellular degradation through a MG132-mediated proteasomal degradation pathway. In the transfected cell lysates, FV-wt protein had multiple posttranslational modified forms, but the FV-Asp68His protein was not completely glycosylated. We further observed that the FV-Asp68His protein was retrieved in the endoplasmic reticulum only and did not undergo transport to the Golgi apparatus, leading to impaired secretion. These results strongly suggest that the Asp68His mutation may result in intracellular defective trafficking and enhanced degradation, and impaired secretion of FV protein.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Functional characterization of a novel missense mutation, His147Arg, in A1 domain of FV protein causing type II deficiency

                Bookmark

                Author and article information

                Journal
                Zhonghua Xue Ye Xue Za Zhi
                Zhonghua Xue Ye Xue Za Zhi
                CJH
                Chinese Journal of Hematology
                Editorial office of Chinese Journal of Hematology (No. 288, Nanjing road, Heping district, Tianjin )
                0253-2727
                2707-9740
                February 2021
                : 42
                : 2
                : 135-139
                Affiliations
                [1 ]温州市中医院检验科 325000Laboratory Department of Wenzhou Chinese Medicine Hospital, Wenzhou 325000, China;
                [2 ]温州医科大学附属第一医院医学检验中心 325015Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China
                Author notes
                通信作者:金艳慧(Jin Yanhui),Email: jyh603@ 123456126.com
                Article
                cjh-42-02-135
                10.3760/cma.j.issn.0253-2727.2021.02.008
                8071673
                33858044
                2d025abd-97e7-45ae-96d4-3fd49ca38d56
                2021年版权归中华医学会所有Copyright © 2021 by Chinese Medical Association

                This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.

                History
                : 15 September 2020
                Funding
                基金项目:温州市卫生健康委员会医药卫生科学研究项目计划(2015B06)
                Fund program: Medical and Health Science Research Project Plan of Health Commission of Wenzhou(2015B06)
                Categories
                论著

                凝血因子ⅴ缺陷症,遗传性,生物信息学,coagulation factor ⅴ deficiency,hereditary,bioinformatics

                Comments

                Comment on this article